The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AMYRIS INC | COM NEW | 03236M200 | 1,800 | 292,398 | SH | SOLE | 292,398 | 0 | 0 | ||
| ATRECA INC | CL A COM | 04965G109 | 23,000 | 1,396,644 | SH | SOLE | 1,396,644 | 0 | 0 | ||
| BIONTECH SE | SPONSORED ADS | 09075V102 | 85,000 | 1,038,674 | SH | SOLE | 1,038,674 | 0 | 0 | ||
| CUREVAC N V | COM | N2451R105 | 254,000 | 3,134,780 | SH | SOLE | 3,134,780 | 0 | 0 | ||
| VIR BIOTECHNOLOGY INC | COM | 92764N102 | 74,000 | 2,777,777 | SH | SOLE | 2,777,777 | 0 | 0 | ||